Weibo Wen

581 total citations
38 papers, 397 citations indexed

About

Weibo Wen is a scholar working on Molecular Biology, Epidemiology and Complementary and alternative medicine. According to data from OpenAlex, Weibo Wen has authored 38 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Epidemiology and 9 papers in Complementary and alternative medicine. Recurrent topics in Weibo Wen's work include Liver Disease Diagnosis and Treatment (10 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Studies (6 papers). Weibo Wen is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Studies (6 papers). Weibo Wen collaborates with scholars based in China. Weibo Wen's co-authors include Huantian Cui, Jiabao Liao, Hongwu Wang, Zhaiyi Zhang, Jie Zhao, Ning Wang, Hanzhou Li, Xuehua Xie, Yuting Li and Fei Qu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Weibo Wen

30 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weibo Wen China 11 189 100 62 58 54 38 397
Jiabao Liao China 11 232 1.2× 133 1.3× 84 1.4× 64 1.1× 62 1.1× 32 418
Qiyuan Shan China 14 272 1.4× 78 0.8× 49 0.8× 91 1.6× 89 1.6× 37 538
Ioana Para Romania 8 123 0.7× 83 0.8× 46 0.7× 32 0.6× 43 0.8× 28 515
Shu-Ju Wu Taiwan 10 199 1.1× 115 1.1× 44 0.7× 121 2.1× 34 0.6× 10 438
Aixin Shi China 11 220 1.2× 48 0.5× 38 0.6× 74 1.3× 48 0.9× 23 479
Xinyu Deng China 13 201 1.1× 127 1.3× 51 0.8× 103 1.8× 49 0.9× 23 513
Jiong Jiang China 10 174 0.9× 117 1.2× 41 0.7× 61 1.1× 26 0.5× 24 483
Yinran Hu China 10 268 1.4× 51 0.5× 56 0.9× 136 2.3× 46 0.9× 10 494
Yongfeng Bai China 10 315 1.7× 96 1.0× 68 1.1× 40 0.7× 24 0.4× 18 519
Naihua Hu China 9 181 1.0× 141 1.4× 32 0.5× 98 1.7× 25 0.5× 11 425

Countries citing papers authored by Weibo Wen

Since Specialization
Citations

This map shows the geographic impact of Weibo Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Wen more than expected).

Fields of papers citing papers by Weibo Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Wen. The network helps show where Weibo Wen may publish in the future.

Co-authorship network of co-authors of Weibo Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Wen. A scholar is included among the top collaborators of Weibo Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Wen. Weibo Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Min, Yifeng Li, Dong Liu, et al.. (2025). Time trends and health inequalities of cirrhosis caused by metabolic Dysfunction-associated steatotic liver disease from 1990 to 2021: A global burden of disease study. Journal of Endocrinological Investigation. 48(11). 2599–2614.
2.
Zhang, Zhongyong, Yuming Wang, Ning Wang, et al.. (2025). Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism. World Journal of Diabetes. 16(5). 103511–103511.
3.
Fan, Min, Xuan Zhang, Tao Tian, et al.. (2025). Crocin inhibits neutrophil migration and activation to treat hypoxic pulmonary hypertension through targeting HCK. Phytomedicine. 148. 157334–157334.
4.
Li, Jiajie, Miao Shao, Jinxing Liu, et al.. (2025). Changes in peridroplet mitochondria during progression of metabolism-associated fatty liver disease. 8(3). 13–13. 1 indexed citations
5.
Cong, Shan, Ning Wang, Zixuan Li, et al.. (2025). Syringin inhibits the crosstalk between macrophages and fibroblast-like synoviocytes to treat rheumatoid arthritis via PDE4. Phytomedicine. 138. 156401–156401. 3 indexed citations
7.
Wang, Ning, Jiabao Liao, Manlin Jin, et al.. (2024). Esculetin rebalances M1/M2 macrophage polarization to treat sepsis‐induced acute lung injury through regulating metabolic reprogramming. Journal of Cellular and Molecular Medicine. 28(21). e70178–e70178. 3 indexed citations
8.
Cui, Huantian, Yutong Jin, Ning Wang, et al.. (2024). Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study. Phytomedicine. 128. 155509–155509. 12 indexed citations
9.
Li, Wenting, Yuting Li, Jie Zhao, et al.. (2024). Release of damaged mitochondrial DNA: A novel factor in stimulating inflammatory response. Pathology - Research and Practice. 258. 155330–155330. 9 indexed citations
10.
Cui, Huantian, Ning Wang, Hanzhou Li, et al.. (2024). The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient "Yin-Yang" theory and modern immunology. Cell Communication and Signaling. 22(1). 99–99. 38 indexed citations
11.
Jin, Lulu, Xin Shang, Le Sun, et al.. (2023). Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism. Phytomedicine. 113. 154733–154733. 50 indexed citations
13.
Guo, Shuang, et al.. (2023). Chemical Fingerprint Analysis and Content Determination of Horned Gallnut and Bellied Gallnut in Galla Chinensis. International Journal of Analytical Chemistry. 2023. 1–10.
14.
Cao, Yongjun, et al.. (2022). Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 6 indexed citations
15.
Cui, Huantian, Yuming Wang, Yu‐Lin Wu, et al.. (2022). Jian-Ti-Kang-Yi decoction alleviates poly(I:C)-induced pneumonia by inhibiting inflammatory response, reducing oxidative stress, and modulating host metabolism. Frontiers in Pharmacology. 13. 979400–979400. 10 indexed citations
16.
17.
Xie, Xuehua, Jiabao Liao, Jie Zhao, et al.. (2021). Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism. Frontiers in Cellular and Infection Microbiology. 11. 748872–748872. 29 indexed citations
18.
Shen, Hongmei, et al.. (2021). Mechanism of Xiaoying Daotan decoction in treating Hashimoto’s thyroiditis based on the Notch/Treg/Th17 pathway. Annals of Translational Medicine. 9(24). 1760–1760. 16 indexed citations
19.
Li, Yuting, Jing Miao, Li Wang, et al.. (2020). Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Cui, Huantian, Yuting Li, Min Cao, et al.. (2020). Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 11. 858–858. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026